Total Payments
$3,905
2024 Payments
$982.83
Companies
27
Transactions
281
Medicare Patients
15,579
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$3,701 (94.8%)
Education$203.30 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,701 | 275 | 94.8% |
| Education | $203.30 | 6 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $754.56 | 54 | $0 (2024) |
| PFIZER INC. | $620.42 | 55 | $0 (2024) |
| Amgen Inc. | $446.50 | 36 | $0 (2024) |
| Novo Nordisk Inc | $394.84 | 35 | $0 (2024) |
| ABBVIE INC. | $357.08 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $338.08 | 21 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $235.70 | 12 | $0 (2024) |
| Amarin Pharma Inc. | $146.13 | 6 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $82.42 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $71.57 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $982.83 | 78 | Lilly USA, LLC ($263.94) |
| 2023 | $866.20 | 59 | Lilly USA, LLC ($232.65) |
| 2022 | $474.41 | 30 | Lilly USA, LLC ($144.63) |
| 2021 | $457.17 | 22 | Astellas Pharma US Inc ($116.78) |
| 2020 | $138.69 | 10 | Amgen Inc. ($39.13) |
| 2019 | $357.89 | 31 | Amgen Inc. ($183.12) |
| 2018 | $355.27 | 30 | Astellas Pharma US Inc ($153.21) |
| 2017 | $272.16 | 21 | PFIZER INC. ($48.46) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: PAIN | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: PAIN | ||||||
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Obesity | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,908 | 15,591 | $988,598 | $407,260 |
| 2022 | 45 | 3,866 | 14,912 | $928,202 | $374,180 |
| 2021 | 46 | 3,992 | 15,009 | $861,031 | $346,141 |
| 2020 | 44 | 3,813 | 14,108 | $796,764 | $317,077 |
Total Patients
15,579
Total Services
59,620
Medicare Billing
$1.4M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 58 | 6,480 | $233,280 | $117,789 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 561 | 1,441 | $246,481 | $111,367 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 434 | 1,024 | $123,535 | $59,703 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 204 | 214 | $23,968 | $16,134 | 67.3% |
| 77067 | Screening mammography | Office | 2023 | 163 | 163 | $34,572 | $13,896 | 40.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 535 | 1,268 | $42,858 | $10,622 | 24.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $9,698 | $7,307 | 75.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 212 | 223 | $6,272 | $6,135 | 97.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 500 | 501 | $42,186 | $6,061 | 14.4% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 41 | 41 | $6,150 | $5,863 | 95.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 28 | $9,849 | $5,860 | 59.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 95 | $6,116 | $4,306 | 70.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 163 | 163 | $7,659 | $3,646 | 47.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 12 | 12 | $22,163 | $3,207 | 14.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 12 | 24 | $9,144 | $2,725 | 29.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $3,968 | $2,472 | 62.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 14 | 14 | $14,727 | $2,393 | 16.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $2,905 | $2,093 | 72.0% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 20 | 21 | $19,706 | $2,072 | 10.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 166 | 243 | $13,122 | $1,849 | 14.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 90 | 105 | $6,951 | $1,647 | 23.7% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 18 | 18 | $16,796 | $1,614 | 9.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 23 | 23 | $5,091 | $1,594 | 31.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 17 | 18 | $8,379 | $1,593 | 19.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 40 | 40 | $3,284 | $1,525 | 46.4% |
About Dr. Gary Williams, MD
Dr. Gary Williams, MD is a Family Medicine healthcare provider based in Salina, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306801626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Williams, MD has received a total of $3,905 in payments from pharmaceutical and medical device companies, with $982.83 received in 2024. These payments were reported across 281 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,701).
As a Medicare-enrolled provider, Williams has provided services to 15,579 Medicare beneficiaries, totaling 59,620 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Salina, KS
- Active Since 04/19/2006
- Last Updated 03/23/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306801626
Products in Payments
- MOUNJARO (Drug) $309.73
- TRULICITY (Drug) $259.68
- VRAYLAR (Drug) $246.59
- Aimovig (Biological) $200.59
- NURTEC ODT (Drug) $188.10
- Ozempic (Drug) $185.84
- ELIQUIS (Drug) $180.86
- Vascepa (Drug) $146.13
- BREZTRI (Drug) $141.70
- PREVNAR - 13 (Biological) $125.50
- Rybelsus (Drug) $113.73
- VESICARE (Drug) $108.76
- UBRELVY (Drug) $101.77
- EVENITY (Biological) $77.38
- NEXLETOL (Drug) $65.03
- PREVNAR 20 (Biological) $64.93
- EMGALITY (Drug) $63.05
- Otezla (Drug) $60.79
- Wegovy (Drug) $57.03
- Prolia (Biological) $56.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Salina
Brett Gray, M.d, M.D
Family Medicine — Payments: $9,903
Family Medicine $9,903
Chadwin Schroeder, Md, MD
Family Medicine — Payments: $7,313
Family Medicine $7,313
William Buck, Md, MD
Family Medicine — Payments: $6,845
Family Medicine $6,845
Lauren Ferrell, M.d, M.D
Family Medicine — Payments: $5,980
Family Medicine $5,980
Kyle Elmore, Md, MD
Family Medicine — Payments: $5,340
Family Medicine $5,340
Amy Hogan, M.d, M.D
Family Medicine — Payments: $4,709
Family Medicine $4,709